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Abstract
Background: Transplantation is the treatment of choice for people with severe organ failure. However, demand
substantially exceeds supply of suitable organs; consequently many people wait months, or years to receive an
organ. Reasons for the chronic shortage of deceased organ donations are unclear; there appears to be no lack of
‘in principle’ public support for organ donation.
Methods/Design: The PAraDOx Study examines community preferences for organ donation policy in Australia. The
aims are to 1) determine which factors influence decisions by individuals to offer their organs for donation and 2)
determine the criteria by which the community deems the allocation of donor organs to be fair and equitable.
Qualitative and quantitative methods will be used to assess community preferences for organ donation and allocation.
Focus group participants from the general community, aged between 18-80, will be purposively sampled to ensure
a variety of cultural backgrounds and views on organ donation. Each focus group will include a ranking exercise
using a modified nominal group technique. Focus groups of organ recipients, their families, and individuals on a
transplant waiting list will also be conducted.
Using the qualitative work, a discrete choice study will be designed to quantitatively assess community preferences.
Discrete choice methods are based on the premise that goods and services can be described in terms of a number of
separate attributes. Respondents are presented with a series of choices where levels of attributes are varied, and a
mathematical function is estimated to describe numerically the value respondents attach to different options. Two
community surveys will be conducted in approximately 1000 respondents each to assess community preferences for
organ donation and allocation. A mixed logit model will be used; model results will be expressed as parameter estimates
(b) and the odds of choosing one option over an alternative. Trade-offs between attributes will also be calculated.
Discussion: By providing a better understanding of current community preferences in relation to organ donation
and allocation, the PAraDOx study will highlight options for firstly, increasing the rate of organ donation and
secondly, allow for more transparent and equitable policies in relation to organ allocation.
Background
There is an increasing recognition of the role and impor-
tance of community preferences in shaping public health
policy. The field of organ donation and transplantation
represents an area where the potential exists for policy to
be made more effective and equitable through the inclu-
sion of community preferences. The most pressing policy
issue in this area is the chronic shortage of organs avail-
able for transplantation in Australia, as reflected in long
waiting lists for transplant. A major factor contributing
to this shortage in Australia is the low rate of organ
donation.
In the PAraDOx study, we will examine two areas of
organ transplant policy making. The first relates to prefer-
ences for organ donation - in particular, the factors that
may influence decisions by members of the public to parti-
cipate in organ donation after death. For instance some of
the factors that may be considered are issues around con-
sent, financial issues, the ability of donors to influence
how their organs are allocated and the success rate of
such transplants. The second relates to allocation of donor
organs. Allocation in Australia, is carried out differently in
different jurisdictions involving varying combinations of
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criteria including tissue matching, length of time on the
waiting list and age. In the PAraDOx study, we will elicit
community preferences for alternative allocation criteria
with the aim of enabling policy to be set in line with com-
munity standards of fairness.
Organ donation
Organ donation predominantly draws on deceased donors,
although more than 40% of kidney donations in Australia
are from living donors [1]. Live kidney donations are
almost always made to known recipients, while organs
from deceased donors are allocated to potential recipients
on the transplant waiting list. In 2007, 1780 people were
on transplant waiting lists around Australia, the vast
majority waiting for kidney transplantation (1394) [2],
with the average wait for a kidney from a deceased donor
being about 4 years [3].
Australia has one of the lowest deceased organ donation
rates in the developed world, with a donor rate of 13.8
donors per million population (dpmp) [2] compared with,
for example, Spain (36.6 dpmp) and the United States
(25.5 dpmp) [4]. Kidney transplantation, by far the most
common form of organ transplant, is widely recognised as
providing superior survival and quality of life over dialysis
and significant cost savings to the community [5]; other
organ transplants are life saving.
The reasons for Australia’s low performance in deceased
organ donation are unclear; there appears to be no lack of
‘in principle’ public support [3]. It is likely that both indivi-
dual specific and systemic features may have an influence:
individuals may register their willingness to donate their
organs on the Australian Organ Donor Register, but ulti-
mately the decision on whether to proceed to organ dona-
tion is made by the next of kin. A report from the
Australian National Clinical Taskforce on Organ and Tis-
sue Donation, established in 2006, highlighted the difficul-
ties experienced by intensive care specialists in discussing
organ donation with families [6]. Improving co-ordination
and communication amongst health care providers may
be one means for improving organ donor rates [3].
Spain with one of the highest organ donation rates in
the world, operates a system of ‘opting out’, where con-
sent is presumed unless stated otherwise. In the UK there
have also been recent moves to adopt a ‘presumed con-
sent’ system [7]. Despite overseas evidence of the effec-
tiveness of such an approach [8], the effectiveness and
ethical implications of such a system in Australia have
not been explored.
Recent initiatives to bolster live donations of kidneys
have also been proposed for Australia, including the
reimbursement of costs to donors along the lines of pro-
grams in New Zealand [9] and Canada [10]. Significant
financial and non-financial incentives have also been put
forward as a means of encouraging donors [11-13]. At
present, legislation across Australia prohibits any eco-
nomic benefit to be furnished to donors reflecting laws in
virtually every other country of the world except Iran
[14]. Nevertheless a number of recent articles have re-
opened the debate in this area, and it is clear that such
payments, backed by effective regulation and harm mini-
misation measures, have strong supporters, particularly
within the transplant and medical communities [11].
International surveys have indicated some support for
broadening the measures available to policy makers to
increase donor rates, including consideration of financial
and non-financial incentives [13,15]. Ultimately the intro-
duction of any such initiative would require first addres-
sing the serious ethical concerns associated with payment
for organs, and to do this we need to understand com-
munity preferences and attitudes surrounding this issue.
Allocation of donor organs
The current shortage of donor organs highlights not only
the need to explore innovative means of increasing supply
but also the means by which existing organs are allocated.
This requires assessment of the underlying principles that
dictate firstly the criteria for including individuals on the
transplant waiting list and then secondly, the basis for the
allocation of available organs to those on the list [6].
There are differences in practices between Australian
states in placing patients on waiting lists, particularly kid-
ney transplant waiting lists [6,16]. There are also differ-
ences in waiting list placement based upon Indigenous
status, with fewer than 5% of people aged under 65 years
on the kidney transplant waiting list being Aboriginal/
Torres Strait Islander patients [16]. These inequities are
recognised by the Clinical Taskforce on Organ and
Tissue Donation [6].
At present, allocation of deceased organs is based on
national and state based algorithms determined largely
by time on waiting list and tissue-matching. The relative
weighting or importance of each of these criteria varies
across state and national jurisdiction, and other criteria
may also come into play. It is unclear how well these cri-
teria accord with community values, and consequently
there is an important role for a community surveys on
these questions.
Policy context
In recent years there has been a growing movement
internationally toward the use of community consulta-
tion in health policy making including major initiatives
in the UK and Canada [17-19]. In Australia, although
there have been some attempts to explicitly use commu-
nity preferences to develop health care policy through
individual small-scale projects [20], the institutionalisa-
tion of such inputs into the policy making process has
generally been limited.
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Community consultation is seen to potentially play a
pivotal role in organ donation and allocation health pol-
icy in Australia. The National Clinical Taskforce on
Organ and Tissue Donation, established in October
2006, was charged with providing evidence-based advice
on ways to improve the rate of safe, effective and ethical
organ and tissue donation for transplantation in Austra-
lia. Six priority areas it considered essential to achieving
national reform in the sector [6] have been indentified,
including increasing community awareness and donor
registration and improving organ allocation systems by
adopting national organ allocation protocols across all
states and territories to improve equity and transpar-
ency. Crucially, it is recognised that a better understand-
ing of community attitudes and preferences for these
issues is required “to ensure that clinicians and policy
makers are in step with community values” [6].
The aims of the PAraDOx study are to
1) determine which factors influence decisions by
individuals to offer their organs for donation and
2) determine the criteria by which the community
deems the allocation of donor organs to be fair and
equitable.
By providing a better understanding of current com-
munity preferences in relation to these issues, it is
expected that the PAraDOx study will highlight options
for firstly, increasing the rate of organ donation and sec-
ondly, allow for more transparent and equitable policies
in relation to organ allocation.
Methods/Design
Overview of approach and methods
The PAraDOx study will utilise both qualitative and
quantitative methods to explore community preferences
and views on 1) organ donation and 2) organ allocation.
Focus groups and one on one interviews will be con-
ducted, and discrete choice methods will be used to
quantitatively assess community preferences for organ
donation and allocation.
Discrete choice experiments (DCEs)
Discrete choice experiments involve surveys in which
respondents are asked to choose between hypothetical
alternatives defined by a set of differing attributes. This
method is becoming more widely used in health as a
means of quantifying patient and consumer preferences
for health care policies and programs [21-24]. The
method is based on the idea that goods and services,
including health care services, can be described in terms
of a number of separate attributes or factors. The levels
of attributes are varied systematically in a series of ques-
tions and respondents choose the option that they prefer
for each question. People are assumed to choose the
option that is most preferred, or has the highest ‘value’.
From these choices, a mathematical function is estimated
which describes numerically the value that respondents
attach to different choice options. Other data collected in
the survey, including attitudinal questions and sociode-
mographic information, may also enter the value func-
tions as explanatory variables. Ultimately, DCE studies
can determine which attributes are driving patient prefer-
ences, the trade-offs between attributes that people are
willing to accept, and how changes in attributes can lead
to changes in preferences and likely service uptake.
Figure 1 illustrates an example from Ratcliffe’s [25,26]
UK survey of community preferences for the allocation
of donor liver grafts for transplantation. The example
involves two unlabelled alternative groups of patients,
Group A and Group B (Figure 1) described using five
different attributes (age, whether patient had alcoholic
liver disease, expected length of post-transplant survival,
time on waiting list, whether it was a first or a re-trans-
plant), each set at specific levels. By presenting respon-
dents with a series of choices where the levels of the
attributes are varied, researchers are able to quantify
how these attributes influence choice. In this example,
the analysis indicates community preferences for allocat-
ing livers to these patient groups based on the relative
weight attached to each attribute.
Given a sufficient number of choices to allow variation
across all attributes, this approach enables estimates of
the marginal effect of each attribute on choice and the
marginal rate of substitution or trade-offs between attri-
butes. In principle this can be done by offering respon-
dents choices using every combination of attributes; a
‘full factorial’ design. In practice such a design is rarely
feasible; efficient designs are therefore paramount, parti-
cularly when considering multiple choice options and
interactions between attributes and socio-demographic
characteristics on choice.
Study Methods
Two sub-studies will be conducted. The first examines
community preferences for organ donation; the second
will examine community preferences for organ alloca-
tion. The same methods and process will be utilised for
each study, as described in the four steps below. The
 Group A Group B 
Age 50 years 40 years 
Alcoholic liver disease Yes No 
Expected length of post-transplant survival 5 years 5 years 
Time on waiting list 12 months 3 months 
Retransplant No Yes 
Figure 1 Example of a discrete choice question.
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study will follow the ISPOR Guidelines for Good
Research Practices for conjoint analysis in health [24].
Stage 1: Focus group methods
Focus groups and one-on-one interviews will be con-
ducted to establish the attributes to be included in the
discrete choice experiments by determining the most
important attributes and the range of feasible values
within each. Focus groups will comprise 10-12 people,
with a broad range of sociodemographic characteristics.
Participants will be recruited via market research com-
panies and will be grouped by age (18-25 years, 26-49
years and 50+ years) to facilitate communication with
their peers. Participants will be purposively sampled to
ensure a balance of numbers between male and female
participants, a variety of cultural backgrounds and vary-
ing views on organ donation. Each focus group will have
three phases; 1) preliminary questions about the partici-
pants’ general thoughts and attitudes to organ donation,
2) a group discussion around factors that would influ-
ence participant’s decisions to be an organ donor and 3)
an individual ranking exercise of the factors identified
from the group discussion. The ranking exercise will be
conducted using a modified nominal group technique
[27-29]. All sessions will be digitally audio-recorded and
transcribed in full.
Additional focus groups of organ recipients and their
families, and individuals on a transplant waiting list will
also be conducted. Patients and families will be con-
tacted through clinics in which the investigators are pre-
sently linked. The number of focus groups conducted
will be based on when data saturation is achieved.
Organ donation
Focus group prompts will include 1) whether they
would be an organ donor 2) whether there is anything
that would make them not want to be an organ donor
3) their understanding of the consent process to become
a donor 4) whether they would consider consenting to
donating a family members organs 5) why they think
Australia has such low donation rates compared to
other western countries 6) what factors would make
them (or others) more likely to donate their organs 7)
what factors do they think are important to people
when they make the decision to donate
Organ allocation
Focus group prompts will include: 1) how they think
organs are allocated in Australia at the moment 2) what
factors do they think should be considered in organ
allocation 3) how should people be prioritised to receive
organs. In addition, the focus groups will be augmented
by one-on-one interviews with a convenience sample of
physicians and surgeons involved in the transplantation
process regarding their thoughts about the organ alloca-
tion policies and practices in Australia.
Focus group analysis
Transcripts will be entered into hyperRESEARCH
(ResearchWare Inc. United States. Version 2.8.3), and
reviewed line by line by the study team. A preliminary
coding system will be developed using a grounded the-
ory approach [30] The data from the focus groups and
interviews will be analysed for emergent themes using
qualitative methods of content and thematic analysis.
Nominal group analysis
Individual respondent rankings will be used to calculate
importance scores for each factor identified in the focus
groups. The highest ranked factor for each respondent
will be given 20 points, the next most important given
19, and so on, progressively down to least important.
Mean importance scores will be calculated. The percen-
tage of respondents who ranked a factor in their top 10
will also be calculated. Differences across sociodemo-
graphic groups (for example age group, non-english
speaking background, Australian state), and across
respondent groups (for example community compared
to patients), will be assessed using analysis of variance
(ANOVA) for differences in mean importance scores of
factors and c2 tests for differences in the proportions of
respondents reporting factors in their top 10 rankings.
Stage 2 Design of Discrete choice questionnaires
Once the attributes have been decided based on the qua-
litative work in Stage 1, a design for the discrete choice
studies will be created. Statistically efficient designs will
be used for both donation and allocation discrete choice
studies. This approach to design links statistical efficiency
to the likely econometric model that is to be estimated
from choice data using the design [31,32]. This approach
often lets go of the orthogonality constraint and attempts
to minimise the expected asymptotic variance-covariance
(AVC) matrix of the design. Efficient choice (EC) designs
therefore attempt to maximise the likely asymptotic
t-ratios obtained from choice data collected. As such,
they attempt to minimize the correlation in the data for
estimation purposes, and collect data such that parameter
estimates have as small as possible standard errors. These
designs make use of the fact that the AVC matrix (the
roots of the diagonal of this matrix are the asymptotic
standard errors) of the parameters can be derived if the
parameters are known. Since the objective of the DCE is
to estimate these parameters, they are unknown at the
time of design. However, if some prior information about
these parameters is available (e.g., parameter estimates
available in the literature from similar studies, or para-
meter estimates from pilot studies), then this AVC matrix
can be determined, assuming that the priors are correct.
Two initial EC designs will be created one for the
organ donation study and one for the organ allocation
study, based on the likely a priori sign of parameters.
Howard et al. BMC Public Health 2011, 11:386
http://www.biomedcentral.com/1471-2458/11/386
Page 4 of 7
These initial designs will be piloted in a sample of 100
respondents for each study, and preliminary models esti-
mated. Parameter estimates from the models will be
used to generate the final efficient designs for the main
discrete choice studies.
In addition to the discrete choice questions, informa-
tion on socidoemographic characteristics of respondents
will also be collected for each survey.
Stage 3: DCE Survey
The DCE survey will be conducted using a web-based
survey with quota sampling based upon age and sex to
recruit a respondent sample broadly representative of
the Australian public. Respondents will be recruited
through a market research company with an existing
online panel and experience in administering online
choice based surveys. Upon consent, the potential
respondent will be referred the online site to complete
the discrete choice survey. Respondents will be asked to
choose between different, unlabelled policy options
which vary across a range of attributes.
Sample Size
The current theory of sampling for these experiments
does not directly address the issue of minimum sample
size requirements in terms of the reliability of the para-
meter estimates produced in the design of stated choice
experiments (see for example, [33,34]). Rather, sampling
theory as applied to choice modelling is designed to
minimise the error in the choice proportions of the alter-
natives under study. This means that the final sample
size required is based upon the characteristics of the
design itself such as the number of attributes included,
the attribute level range, the number of choice scenarios
presented, the number of alternatives in each choice set
and the size and direction of prior parameters obtained
from the pilot study. To ensure that the population
responses are broadly generalisable to the Australian
adult population, and that we are able to explore interac-
tions between attributes and between attributes and
sociodemographic factors, and present subgroup analyses
we anticipate a sample size of approximately 1000
respondents for each of the two surveys.
Stage 4: Analysis
The results from this survey will inform policy by high-
lighting the factors that are likely to influence an indivi-
dual’s decision to become an organ donor and the
factors that the community perceives as most important
in the allocation of donor organs to those on transplant
waiting lists.
A mixed multinomial logit (MMNL) (also known as
random parameters logit, RPL) model using a panel size
specification will be used for each analysis. A panel spe-
cification of the model allows for non-independence of
observations provided by the same respondent; that is it
can account for correlations amongst the multiple
choices made by the same individual. MMNL models
relax certain statistical assumptions of more commonly
used multinomial logit (MNL) models, and often lead to
models that better explain choice behaviour [33]. In
MNL choice models, commonly used in health econom-
ics, parameters associated with each attribute are treated
as fixed. These fixed values are the average (or point
estimates) associated with a population level distribu-
tion; other information in the distribution is not con-
sidered. A MMNL allows consideration of the full
distribution of a parameter estimate, and the fixed para-
meter becomes a random parameter. ‘Random para-
meter’ simply implies that each individual has an
associated parameter estimate on that specified distribu-
tion. Whilst the exact location of each individual’s pre-
ferences on the distribution may not be known,
estimates of ‘individual-specific preferences ’ can be
accommodated by deriving the individual’s conditional
distribution, based - within sample - on their choices
(i.e. prior knowledge) [35]. Interactions between attri-
butes in the discrete choice surveys, and between attri-
butes and population characteristics (for example, age,
gender, income, education, knowledge of anyone who
has received a transplant, non-english speaking back-
ground) will be explored in the mixed logit analysis for
both studies.
Model results will expressed as parameter estimates
(b), the odds of choosing one option instead of another
(and 95% confidence intervals of the odds ratios) and p-
values. Acceptable trade-offs between attributes will also
be calculated.
Ethical considerations
The PAraDOx study has been approved by the Univer-
sity of Sydney, Human Research Ethics Committee (Pro-
tocol numbers 12783, 12848 and 04-2011/13602),
Sydney South West Area Health Service Ethics Review
Committee (HREC/10/RPAH/23) and Sydney West
Area Health Service Ethics Review Committee (SSA/10/
WMEAD/92).
Confidentiality and anonymity of the data will be
strictly maintained. Digital recording of the focus groups
and physician interviews will only take place after writ-
ten informed consent is obtained from participants. Par-
ticipants will not be identifiable in any transcripts, or in
any publications. It will be made clear to all participants
that they have the right to withdraw from the research
at any point in time.
As the population survey will be conducted as an
online survey, written consent is not possible. As such
participant information for the online survey will include
the following statement “Being in this study is completely
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voluntary - you are not under any obligation to consent
and - if you do consent - you can withdraw at any time
without affecting your relationship with The University
of Sydney. By completing the survey you have consented
to be part of the study. You may stop completing the
online survey at any point if you do not wish to continue,
and we will not use your answers. Once you have sub-
mitted your survey anonymously, your responses cannot
be withdrawn”. As the survey is administered online, the
study team will not have access to any information that
could be used to identify respondents.
Discussion
The PAraDOx study is a comprehensive analysis of
community preferences for organ donation and organ
allocation. Using qualitative and quantitative methods
PAraDOx will provide an understanding of the views
and preferences of the Australian community on alter-
native possible policy options for organ donation and
allocation. Specifically, the aims of the PAraDOx study
are to 1) determine which factors influence decisions by
individuals to offer their organs for donation and 2)
determine the criteria by which the community deems
the allocation of donor organs to be fair and equitable.
The analysis will provide:
- Estimates of the marginal effect (importance) of
each attribute on overall choice, e.g. if a payment
attribute is presented in the study on organ dona-
tion, the analysis will provide an estimate of relative
importance of receiving a payment on respondents’
decision to donate.
- Estimates of marginal rates of substitution between
attributes based on the ratio of parameter estimates,
giving an indication of the extent to which respon-
dents are prepared to trade-off one attribute for
another. E.g. if payment and ability to influence
organ recipient are offered as attributes in the sur-
vey, the marginal rate of substitution between these
reflects the payment people are willing to accept as
a trade-off for the ability to influence the recipient.
- An indication of the predicted uptake associated
with different parameter levels within the estimated
utility functions. This allows forecasting of, for
instance, the level of organ donation uptake that
could be expected given particular policy criteria
(e.g. different types or levels of payment and ability
to influence allocation) and socio-demographic
characteristics.
By providing a better understanding of current com-
munity preferences in relation to these issues, the PAra-
DOx study will highlight options for firstly, increasing
the rate of organ donation and secondly, allow for more
transparent and equitable policies in relation to organ
allocation.
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